Actualités Metavista3D Inc - DDD | Actions TSX Venture Exchange

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

SCOLR Pharma, Inc. Licenses Dietary Supplements

BOTHELL, Wash., Dec. 1 /PRNewswire-FirstCall/ -- SCOLR Pharma, Inc. (NYSE Amex: DDD) announced that on November 20, 2009 it licensed to Chrono...

SCOLR Pharma, Inc. Receives Notices From NYSE Amex LLC Regarding Compliance Plan and Listing Standards

BOTHELL, Wash., Nov. 30 /PRNewswire-FirstCall/ -- SCOLR Pharma, Inc. (NYSE Amex: DDD) announced today that on November 25, 2009, the NYSE Amex...

SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results

BOTHELL, Wash., Nov. 6 /PRNewswire-FirstCall/ -- SCOLR Pharma, Inc. (AMEX: DDD) today reported financial results for the three and nine months...

SCOLR Pharma, Inc. Receives Notice from NYSE Amex LLC Regarding Compliance Plan and Listing Standards

BOTHELL, Wash., Sept. 18 /PRNewswire-FirstCall/ -- SCOLR Pharma, Inc. (NYSE Amex: DDD) announced today that on September 15, 2009, the NYSE Amex...

SCOLR Pharma, Inc. Appoints Stephen J. Turner as CEO

BOTHELL, Wash., Aug. 31 /PRNewswire-FirstCall/ -- SCOLR Pharma, Inc. (NYSE Amex: DDD) announced the appointment of Stephen J. Turner as Chief...

SCOLR Pharma, Inc. Reports Second Quarter 2009 Financial Results

BOTHELL, Wash., Aug. 7 /PRNewswire-FirstCall/ -- SCOLR Pharma, Inc. (NYSE Amex: DDD) today reported financial results for the three and six...

SCOLR Pharma, Inc. Reports First Quarter 2009 Financial Results

BOTHELL, Wash., May 1 /PRNewswire-FirstCall/ -- SCOLR Pharma, Inc. (NYSE Amex: DDD) reported financial results for the three months ended March...

SCOLR Pharma, Inc. Schedules First Quarter 2009 Financial Results Conference Call for May 1, 2009 at 11:30 A.M. Eastern

BOTHELL, Wash., April 29 /PRNewswire-FirstCall/ -- SCOLR Pharma, Inc. (NYSE Alternext US: DDD) today announced plans to release first quarter...

SCOLR Pharma, Inc. Announces Engagement of HealthPro as Financial Advisor

BOTHELL, Wash., April 2 /PRNewswire-FirstCall/ -- SCOLR Pharma, Inc. (NYSE Alternext US: DDD) today announced the engagement of HealthPro...

SCOLR Pharma, Inc. Reports Fourth Quarter 2008 Financial Results

BOTHELL, Wash., March 11 /PRNewswire-FirstCall/ -- SCOLR Pharma, Inc. (NYSE Alternext US: DDD) today reported financial results for the three...

SCOLR Pharma, Inc. Schedules Fourth Quarter 2008 Financial Results Conference Call for March 11, 2009 at 11:30 A.M. Eastern

BOTHELL, Wash., March 5 /PRNewswire-FirstCall/ -- SCOLR Pharma, Inc. (NYSE Alternext US: DDD) today announced plans to release fourth quarter...

SCOLR Pharma, Inc. Announces Appointment of Bruce S. Morra, Ph.D., as President & CEO

BOTHELL, Wash., Feb. 2 /PRNewswire-FirstCall/ -- SCOLR Pharma, Inc. (NYSE Alternext US: DDD) today announced that the board of directors has...

SCOLR Pharma, Inc. Announces Resignation of CEO Daniel O. Wilds

BOTHELL, Wash., Dec. 16 /PRNewswire-FirstCall/ -- SCOLR Pharma, Inc. (NYSE Alternext: DDD) today announced that Daniel O. Wilds had resigned as...

SCOLR Pharma, Inc. Announces Positive Top-Line Results From Pivotal Clinical Trial Evaluating Efficacy of Extended-Release Ibupr

Pivotal Phase III Trial Primary Endpoints Achieved for SCOLR's 12 Hour Ibuprofen BOTHELL, Wash., Nov. 6 /PRNewswire-FirstCall/ -- SCOLR Pharma...

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Metavista3D Inc (DDD)

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

DDD Actualités

SCOLR Pharma, Inc. Licenses Dietary Supplements

SCOLR Pharma, Inc. Receives Notices From NYSE Amex LLC Regarding Compliance Plan and Listing Standards

SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results

SCOLR Pharma, Inc. Receives Notice from NYSE Amex LLC Regarding Compliance Plan and Listing Standards

SCOLR Pharma, Inc. Appoints Stephen J. Turner as CEO

SCOLR Pharma, Inc. Reports Second Quarter 2009 Financial Results

SCOLR Pharma, Inc. Reports First Quarter 2009 Financial Results

SCOLR Pharma, Inc. Schedules First Quarter 2009 Financial Results Conference Call for May 1, 2009 at 11:30 A.M. Eastern

SCOLR Pharma, Inc. Announces Engagement of HealthPro as Financial Advisor

SCOLR Pharma, Inc. Reports Fourth Quarter 2008 Financial Results

SCOLR Pharma, Inc. Schedules Fourth Quarter 2008 Financial Results Conference Call for March 11, 2009 at 11:30 A.M. Eastern

SCOLR Pharma, Inc. Announces Appointment of Bruce S. Morra, Ph.D., as President & CEO

SCOLR Pharma, Inc. Announces Resignation of CEO Daniel O. Wilds

SCOLR Pharma, Inc. Announces Positive Top-Line Results From Pivotal Clinical Trial Evaluating Efficacy of Extended-Release Ibupr

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Metavista3D Inc (DDD) Actualités

Metavista3D Inc (DDD)

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

DDD Actualités

SCOLR Pharma, Inc. Licenses Dietary Supplements

SCOLR Pharma, Inc. Receives Notices From NYSE Amex LLC Regarding Compliance Plan and Listing Standards

SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results

SCOLR Pharma, Inc. Receives Notice from NYSE Amex LLC Regarding Compliance Plan and Listing Standards

SCOLR Pharma, Inc. Appoints Stephen J. Turner as CEO

SCOLR Pharma, Inc. Reports Second Quarter 2009 Financial Results

SCOLR Pharma, Inc. Reports First Quarter 2009 Financial Results

SCOLR Pharma, Inc. Schedules First Quarter 2009 Financial Results Conference Call for May 1, 2009 at 11:30 A.M. Eastern

SCOLR Pharma, Inc. Announces Engagement of HealthPro as Financial Advisor

SCOLR Pharma, Inc. Reports Fourth Quarter 2008 Financial Results

SCOLR Pharma, Inc. Schedules Fourth Quarter 2008 Financial Results Conference Call for March 11, 2009 at 11:30 A.M. Eastern

SCOLR Pharma, Inc. Announces Appointment of Bruce S. Morra, Ph.D., as President & CEO

SCOLR Pharma, Inc. Announces Resignation of CEO Daniel O. Wilds

SCOLR Pharma, Inc. Announces Positive Top-Line Results From Pivotal Clinical Trial Evaluating Efficacy of Extended-Release Ibupr

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application